Market revenue in 2023 | USD 54,265.8 million |
Market revenue in 2030 | USD 124,989.3 million |
Growth rate | 12.7% (CAGR from 2023 to 2030) |
Largest segment | Pharmaceutical outsourcing |
Fastest growing segment | Medical devices outsourcing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pharmaceutical outsourcing, Medical devices outsourcing, Contract sales and marketing outsourcing |
Key market players worldwide | Atos SE, Boehringer Ingelheim, Catalent Inc, Labcorp Drug Development, Genpact Ltd, Icon PLC, Infosys Ltd ADR, International Business Machines Corp, Lonza Group Ltd, PAREXEL, IQVIA Holdings Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to life sciences bpo market will help companies and investors design strategic landscapes.
Pharmaceutical outsourcing was the largest segment with a revenue share of 55.13% in 2023. Horizon Databook has segmented the China life sciences bpo market based on pharmaceutical outsourcing, medical devices outsourcing, contract sales and marketing outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the China life sciences bpo market, including forecasts for subscribers. This country databook contains high-level insights into China life sciences bpo market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account